Autopsy report · NCT01947309

Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Business Decision”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 2 years 10 months before it stopped.
176 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: Celgene
Sponsor type: Industry
Conditions: Multiple Myeloma
Interventions: Revlimid (lenalidomide)
Participants: 176
Sites: 17
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.